Searched for
PRIVATE PATHOLOGY LABS
For investors with patience, experience, and anxiety appetite: 5 stocks from different sectors with upside potential of up to 21%- Amazon, not the first, nor the last to attempt disruption. 5 diagnostics stocks: From downside forecast, to upside as high as 67%
- Is valuation readjustment over? Time to look at them again? 4 stocks from the diagnostics sector with upside potential of 11 to 25%
- Do Dr Lal Pathlabs' results indicate a turnaround for the sector? 4 stocks from diagnostic space, 3 with upside potential of up to 31%Some sectors have a company which can be called as the bell weather of that sector and that is why its results of that company probably are...11 May, 2024, 04.29 PM IST
- Price wars are still on but... 4 stocks from diagnostics sector have upside potential of up to 26%In the last five years, the diagnostic segment of the healthcare sector has seen many ups and downs. During Covid, diagnostic players were ...04 Nov, 2023, 03.59 PM IST
- There is a place in our country for many Dr Lal Path Labs, not just one: Arvind Lal“Competition is always very good for one’s business and who can say it better than us because we have seen all kinds of raiders from wester...14 Dec, 2022, 03.44 PM IST
- Krsnaa Diagnostics plans 600 testing centres by end of FY24Krsnaa is banking on the B2C (business-to-customer) model, besides bidding for more PPP contracts to double revenue growth and triple profi...25 Nov, 2022, 11.26 AM IST
- Motilal Oswal Private Equity invests RS 194.4 crore in Pathkind DiagnosticsEstablished in 2016, Pathkind is one of the fastest growing diagnostics services chains in India with a network of over 75 labs of which 13...20 May, 2022, 07.46 PM IST
- Covid-19: Testing delays a big issue in Uttar PradeshExecutives working at collection centres of prominent diagnostic chains Dr Lal Path-Labs and SRL Diagnostics said they have not been collec...17 Apr, 2021, 11.36 AM IST
- Diagnostics chain HealthMaP looks at merger with iGeneticUnder the proposed deal, HealthMap will get access to iGenetic’s core markets in Mumbai and other profit-making regions. “The idea is to me...06 Apr, 2021, 11.10 AM IST
- 244 free COVID-19 testing centres started in MumbaiA person with COVID-19 symptoms can dial helpline number 1916 or visit the BMC's dedicated webpage 'http:topcoronavirus.mcgm.gov.in' for in...02 Nov, 2020, 12.21 PM IST
- Covid-19: Telangana’s poor nos due to testing by only government labsBehind Telangana’s low testing numbers, which have come under the scanner of the Centre, is the state government’s insistence to test only ...08 May, 2020, 07.13 AM IST
- Trivitron, Neuberg may expand to Africa, MideastGSK Velu, founder of both companies, is looking at aggressively acquiring pathology chains and medical equipment makers in these markets th...02 May, 2019, 02.30 PM IST
- Metropolis Health to file DRHP to raise Rs 2,000 crThe diagnostic market in India is about $8 bn, and growing at a CAGR of 12 per cent.27 Sep, 2018, 09.26 AM IST
- CSIR authorises private path lab for genetic testsNew Delhi, March 9 (IANS) Hoping to use private pathology labs to reach out to people, the Council of Scientific and Industrial Research (C...09 Mar, 2018, 12.17 AM IST
- Entrepreneur Velu back in diagnosticsThe re-entry puts him in direct competition with his former partner, Ameera Shah.14 Dec, 2017, 02.12 PM IST
- Metropolis acquires Sanjeevani Pathology Labs in an all-cash transactionMetropolis has adopted a string of pearls strategy by either partnering or acquiring smaller brands in newer markets.03 Feb, 2017, 12.50 PM IST
- J P Nadda asks Delhi government to implement law to regulate private clinicsExpressing concern over growing number of unregulated pathological labs and clinics, Health Minister J P Nadda urged the Delhi government.26 Feb, 2016, 06.54 PM IST
- Delhi government puts price cap of Rs 4,500 for swine flu testTwo of the leading private pathology labs in the city, Dr Dangs Dr Lal, told TOI that they would abide by the government order.19 Feb, 2015, 11.46 AM IST
- Dr Lal PathLabs may make public market debut next fiscalDr Lal PathLabs is undertaking a restructuring exercise to determine the issue size of its potential IPO and a decision is expected by Dece...25 Sep, 2014, 06.07 PM IST
Load More
